These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3545614)

  • 1. Nifedipine. Relationship between pharmacokinetics and pharmacodynamics.
    Kleinbloesem CH; van Brummelen P; Breimer DD
    Clin Pharmacokinet; 1987 Jan; 12(1):12-29. PubMed ID: 3545614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nifedipine: influence of renal function on pharmacokinetic/hemodynamic relationship.
    Kleinbloesem CH; van Brummelen P; van Harten J; Danhof M; Breimer DD
    Clin Pharmacol Ther; 1985 May; 37(5):563-74. PubMed ID: 3987180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nifedipine: kinetics and hemodynamic effects in patients with liver cirrhosis after intravenous and oral administration.
    Kleinbloesem CH; van Harten J; Wilson JP; Danhof M; van Brummelen P; Breimer DD
    Clin Pharmacol Ther; 1986 Jul; 40(1):21-8. PubMed ID: 3720176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical pharmacokinetics of verapamil, nifedipine and diltiazem.
    Echizen H; Eichelbaum M
    Clin Pharmacokinet; 1986; 11(6):425-49. PubMed ID: 3542336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and hemodynamic effects of long-term nifedipine treatment in hypertensive patients.
    Kleinbloesem CH; van Brummelen P; Faber H; Breimer DD
    J Cardiovasc Pharmacol; 1987 Feb; 9(2):202-8. PubMed ID: 2435999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nifedipine: kinetics and dynamics in healthy subjects.
    Kleinbloesem CH; van Brummelen P; van de Linde JA; Voogd PJ; Breimer DD
    Clin Pharmacol Ther; 1984 Jun; 35(6):742-9. PubMed ID: 6734025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and pharmacodynamics of nifedipine infusion in normal volunteers.
    Walley TJ; Heagerty AM; Woods KL; Bing RF; Pohl JE; Barnett DB
    Br J Clin Pharmacol; 1987 Jun; 23(6):693-701. PubMed ID: 3606929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and pharmacodynamics of nifedipine in patients at steady state.
    Gutierrez LM; Lesko LJ; Whipps R; Carliner N; Fisher M
    J Clin Pharmacol; 1986; 26(8):587-92. PubMed ID: 3793948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of food and posture on the pharmacokinetics of a biphasic release preparation of nifedipine.
    Challenor V; Waller DG; Gruchy BS; Renwick AG; George CF; McMurdo ET; McEwen J
    Br J Clin Pharmacol; 1986 Nov; 22(5):565-70. PubMed ID: 3790403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and pharmacodynamics of conventional and slow release forms of nifedipine in essential hypertensive patients.
    Imai Y; Abe K; Sasaki S; Nihei M; Sekino H; Yoshinaga K
    Tohoku J Exp Med; 1986 Apr; 148(4):421-38. PubMed ID: 3738908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of haemodialysis on the pharmacokinetics and haemodynamic effects of nifedipine during continuous intravenous infusion.
    Kleinbloesem CH; van Brummelen P; Woittiez AJ; Faber H; Breimer DD
    Clin Pharmacokinet; 1986; 11(4):316-22. PubMed ID: 3757391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and pharmacodynamics of two commercial oral nifedipine products.
    Shaheen O; Zmeili S; al-Qussuois Y; Arafat T; Mouti H
    Int J Clin Pharmacol Ther Toxicol; 1991 Sep; 29(9):337-41. PubMed ID: 1937993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in nifedipine concentration-effect relationship between capsule and slow release tablet administration.
    Castañeda-Hernández G; Hoyo-Vadillo C; Herrera JE
    Int J Clin Pharmacol Ther; 1995 Jan; 33(1):56-60. PubMed ID: 7711994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of calcium channel blocking agents.
    Anderson P
    Acta Pharmacol Toxicol (Copenh); 1986; 58 Suppl 2():43-57. PubMed ID: 2940799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and bioavailability of three different galenic nifedipine preparations.
    Pabst G; Lutz D; Molz KH; Dahmen W; Jaeger H
    Arzneimittelforschung; 1986 Feb; 36(2):256-60. PubMed ID: 3964332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute antihypertensive effect and pharmacokinetics of a tablet preparation of nifedipine.
    Banzet O; Colin JN; Thibonnier M; Singlas E; Alexandre JM; Corvol P
    Eur J Clin Pharmacol; 1983; 24(2):145-50. PubMed ID: 6840159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of nifedipine.
    Pasanisi F; Meredith PA; Reid JL
    Int J Clin Pharmacol Res; 1985; 5(1):63-6. PubMed ID: 3997314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative pharmacokinetics of different oral nifedipine preparations in healthy Brazilian volunteers.
    Vianna-Jorge R; Sudo RT; Melo PA; Suarez-Kurtz G
    Braz J Med Biol Res; 1992; 25(4):385-91. PubMed ID: 1342215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clevidipine: a review of its use in the management of acute hypertension.
    Deeks ED; Keating GM; Keam SJ
    Am J Cardiovasc Drugs; 2009; 9(2):117-34. PubMed ID: 19331440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Bioavailability of new nifedipine preparations in man. 1. Pharmacokinetics of nifedipine in the form of sustained-release tablets].
    Lutz D; Pabst G; Dahmen W; Molz KH; Jaeger H
    Arzneimittelforschung; 1985; 35(12):1840-2. PubMed ID: 4096741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.